Webinar: Coming to America

 Practical considerations for expanding your business to the US market

Program for June 7, 2022 - Timezone: EST (US Eastern)

10.00 am - Bioregion Boston/Cambridge

                   Jared Auclair, Associate Dean of Professional Programs and Graduate Affairs

                   at Northeastern University, Boston, MA

10.20 am - Role of a local partner to support a US expansion

                   Dr. Odilo Mueller, President, CYTO Consulting, Woburn, MA

10.40 am - Q&A: Ask the expert about their successful US expansion

                   Dieter Lingelbach, Chief Operating Officer at Sirion Biotech GmbH,

                   Graefelfing, Germany

11.00 am -  End of Program

Registration form

arrow&v

Thanks for registering to our event. See you there!

The Speakers

Jared_Auclair_1.png

JARED R. AUCLAIR, PHD

Associate Dean, Northeastern University, Boston, MA

Jared R. Auclair is currently the Associate Dean of Professional Program and Graduate Affairs in the College of Science at Northeastern University and Associate Teaching Professor in the department of chemistry and chemical biology.

 

In addition, Dr. Auclair is the Director of the Biopharmaceutical Analysis Laboratory (BATL), the Asia-Pacific Economic Cooperation Center of Regulatory Excellence in Biotherapeutics and Advanced Therapies and oversees the International Council for Harmonisation training.

 

Lastly, Prof. Auclair serves as the Technical Supervisor for the Life Science Testing Center at Northeastern University, which is a state and CLIA-certified lab.

 

Prior to joining Northeastern, Dr. Auclair received his bachelor’s degree in biotechnology from Worcester Polytechnic Institute and a PhD in Biomedical Science from the University of Massachusetts Medical. Upon graduating with his PhD, he did a post-doc under Greg Petsko, Dagmar Ringe and Jeffrey Agar at Brandeis

Dieter Lingelbach.jpg

DIETER LINGELBACH, MBA

Chief Business Officer

Dieter has a longstanding general management experience with both Roche Diagnostics, Roche Applied Science and MorphoSys. Today, the latter is one of the world’s leading bio-technology companies on the basis of its proprietary antibody platform. Earlier, Dieter worked several years with Booz & Company’s healthcare practice after receiving his MBA from Indiana University as a Fulbright Scholar.

 

ODILO MUELLER, PHD

President, CYTO Consulting

Odilo is the founder and president of CYTO Consulting. Odilo started CYTO Consulting in 2014 with the vision to help international life science companies with the successful commercialization of novel technologies. Having first-hand experience with the very successful launch of the world’s first analytical microfluidics platform, he focuses on helping international companies to avoid common mistakes and to maximize their return on investment. 

As a global strategist with a proven ability in assessing future needs and opportunities, Odilo has helped develop innovations and drive business growth for over 25 years during his leadership roles in leading diagnostic and life science companies such as Agilent, Merck/Millipore, Abcam, and Danaher/AB SCIEX.  

Odilo received his Ph.D. in Analytical Biochemistry from Northeastern University and a BS in Chemistry from Saarland University in Germany. 

Entering the US market is a significant challenge. While the overall approach seems straightforward enough and may look good on paper, the real issues arise when starting to implement the commercialization plan. For many small to mid-size companies this can be a daunting task. CYTO Consulting has been helping clients to de-risk the US market entry for more than 7 years.

 

In this seminar, we will discuss the practical aspects of expanding a business to the US market and invite international life science companies to establish a presence in the US. Especially in the Boston/Cambridge area - the biggest biotech hub in the world. It’s closer than you think!

Odilo_OurTeam2.JPG